If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaker Steel Regulatory News (BSRT)

Share Price Information for Baker Steel (BSRT)

Share Price is delayed by 15 minutes
Get Live Data
127.00    1.00 (0.79%)
Bid:
122.00
Ask:
127.00
Spread: 5.00 (4.098%)
Market Cap: £133.72m
BSRT Live PriceLast checked at - London Stock Exchange

Intraday Baker Steel Share Chart

Net Asset Value(s)

4 Nov 2021 10:30

RNS Number : 3547R
Baker Steel Resources Trust Ltd
04 November 2021
 

 

 

BAKER STEEL RESOURCES TRUST LIMITED

(Incorporated in Guernsey with registered number 51576 under the provisions of The Companies (Guernsey) Law, 2008 as amended)

 

4 November 2021

29 October 2021 Unaudited NAV Statement

Net Asset Value

Baker Steel Resources Trust Limited (the "Company") announces its unaudited net asset value per share at 29 October 2021:

Net asset value per Ordinary Share: 97.7 pence

The NAV per share has increased by 0.7% against the unaudited NAV at 30 September 2021, mainly due an increase in the carrying value of Tungsten West Plc following its successful IPO on AIM during the month.

 

The Company had a total of 106,462,502 Ordinary Shares in issue with a further 700,000 shares held in treasury as at 29 October 2021.

 

Investment Update

 

The Company's top 12 investments were as follows as a percentage of NAV:

 

 

29 October 2021

31 December 2020

Bilboes Gold Limited

19.3%

19.5%

Futura Resources Ltd

16.4%

16.2%

Tungsten West Plc

15.9%

13.2%

Cemos Group plc

13.8%

14.5%

Polar Acquisition Ltd

8.7%

8.9%

First Tin Ltd

5.2%

3.9%

Mines & Metals Trading Peru PLC/Silver X Mining Corporation

4.1%

4.5%

Nussir ASA

4.0%

3.4%

Kanga Potash

2.7%

2.7%

Azarga Metals Corp

2.6%

2.7%

Prism Diversified

1.6%

1.5%

Metals Exploration plc

1.5%

1.9%

Listed Precious Metal Shares

1.8%

3.9%

Other Investments

1.9%

2.4%

Net Cash, Equivalents and Accruals

0.5%

0.8%

 

Tungsten West Plc (Tungsten West)

 

Tungsten West commenced trading on the AIM market of the London Stock Exchange during October 2021 following an IPO at 60p per share raising £39 million. The target amount to be raised was £25 million, however the Board of Tungsten West, on which the Company is represented, decided to accept additional applications, as the increased equity raising provides extra contingency in case of capital overruns or delays or otherwise reduces the amount of loan than will need to be drawn down thereby reducing the financing risk of the project. As a part of the IPO, the Company's convertible loan was converted into ordinary shares such that the Company is now Tungsten West's largest shareholder with 15.35% of its issued shares.

 

As one of 4 founders the Company has been issued options over a total of 4,971,585 shares. The options are exercisable in three equal tranches for a nominal amount dependent on certain corporate milestones being achieved. The milestone for the first tranche was the IPO and is therefore immediately exercisable. The second tranche is exercisable when the Hemerdon mine is fully financed to production, which should be achieved once the various conditions precedent to the US$49 million royalty and loan facility from Orion Resource Partners (UK) LLP are fulfilled. This is expected in the first half of 2022. The third tranche is exercisable on commercial production at Hemerdon, expected in 2023.

 

As the Company is a substantial shareholder in Tungsten West, its shareholding is subject to a one year lock-up in accordance with AIM rules. The Company using a Black Scholes option valuation methodology is carrying its Tungsten West shares at a 25% discount) to the 29 October 2021 market bid price on AIM, albeit this discount should decrease as the time remaining on the lock-in reduces. The carrying values of tranches 2 and 3 of the options are discounted further to allow for the risk of the milestones not being achieved.

 

Tungsten West is the 100 per cent. owner and operator of the historical Hemerdon tungsten and tin mine located near Plymouth in southern Devon, England. The Hemerdon Mine represents the world's third largest tungsten mineral resource, with a JORC Code (2012) compliant Mineral Resource Estimate of approximately 325Mt at 0.12 per cent. WO3. Tungsten West identified a number of reasons which it believes contributed to the failure of the previous operations at the Hemerdon Mine and has devised a new operating plan which aims to remedy these to enable it to recommence operations with significantly improved operational efficiencies and financial profitability.

 

Tungsten West's financial model estimates planned capital expenditure and corporate commitments of £44.6 million for improvement works at the Hemerdon Mine. It has an estimated 18.5 year life of mine, generating a NPV5% of £272 million and an IRR of 45 per cent. The ramp up in production is planned to commence in Q4 2022, reaching steady state production within eight months, when operations are expected to produce approximately 3.5ktpa WO3 and 388tpa Sn generating an average of £34 million EBITDA per annum over the life of the Hemerdon Mine.

 

The Company is pleased to have been instrumental in Tungsten West's formation and the acquisition of the Hemerdon Mine, which promises to be an important strategic producer of tungsten outside of the main producing country, China. The Company's average cost in acquiring its equity position was approximately 20.3p per Tungsten West share compared to the closing bid price of 70p on 29 October 2021 and 76p on 2 November 2021.

 

 

Further details of the Company and its investments are available on the Company's website www.bakersteelresourcestrust.com 

 

 

Enquiries:

Baker Steel Resources Trust Limited +44 20 7389 8237

Francis JohnstoneTrevor Steel

 

Numis Securities Limited +44 20 7260 1000

David Benda (corporate)

James Glass (sales)

 

The Net Asset Value ("NAV") figure stated is based on unaudited estimated valuations of the underlying investments and not necessarily based on observable inputs. Such estimates are not subject to any independent verification or other due diligence and may not comply with generally accepted accounting practices or other generally accepted valuation principles. In addition, some estimated valuations are based on the latest available information which may relate to some time before the date set out above.

 

Accordingly, no reliance should be placed on such estimated valuations and they should only be taken as an indicative guide. Other risk factors which may be relevant to the NAV figure are set out in the Company's Prospectus dated 26 January 2015.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVMZMGMLDFGMZG
Date   Source Headline
11th Nov 20257:00 amRNSInvestment Update and 31 October 2025 NAV
7th Oct 20257:00 amRNSInvestment Update and 30 September 2025 NAV
30th Sep 20257:00 amRNSHalf-year Report
25th Sep 20259:36 amRNSResult of AGM
4th Sep 20259:19 amRNSInvestment Update and 29 August 2025 NAV
1st Sep 20257:00 amRNSNotice of AGM
12th Aug 20257:00 amRNSInvestment Update and 31 July 2025 NAV
14th Jul 20257:00 amRNSInvestment Update and 30 June 2025 NAV
2nd Jul 20257:00 amRNSPAL - Sale of Prognoz Royalty Interest
6th Jun 20257:00 amRNSInvestment Update and 30 May 2025 NAV
9th May 20257:00 amRNSFutura Financing and Potential Transaction
8th May 20257:00 amRNSInvestment Update and 30 April 2025 NAV
28th Apr 20257:00 amRNSAnnual Financial Report
9th Apr 20257:00 amRNSInvestment Update and 31 March 2025 NAV
10th Mar 20257:00 amRNSInvestment Update and 28 February 2025 NAV
10th Feb 20257:00 amRNSInvestment Update and 31 January 2025 NAV
17th Jan 20257:00 amRNSInvestment Update and 31 December 2024 NAV
31st Dec 20247:00 amRNSChair Succession
9th Dec 20247:00 amRNSNet Asset Value(s)
29th Nov 20247:00 amRNSConditional agreement to sell Nussir ASA
8th Nov 20247:00 amRNSNet Asset Value(s)
14th Oct 20247:00 amRNSAppointment of Corporate Broker
9th Oct 20247:00 amRNSNet Asset Value(s)
13th Sep 20247:00 amRNSHalf-year Report
12th Sep 20245:52 pmRNSResult of AGM
6th Sep 20241:15 pmRNSNet Asset Value(s)
15th Aug 20243:30 pmRNSNotice of AGM
9th Aug 20247:00 amRNSNet Asset Value(s)
9th Jul 20247:00 amRNSNet Asset Value(s)
25th Jun 20242:30 pmRNSAppointment of Director
5th Jun 20247:00 amRNSNet Asset Value(s)
14th May 20241:50 pmEQSEdison issues review on Baker Steel Resources Trust (BSRT): Potential to generate a 20%+ yield
13th May 20247:00 amRNSNet Asset Value(s)
29th Apr 20247:00 amRNSAnnual Financial Report
8th Apr 20247:00 amRNSNet Asset Value(s)
8th Mar 20247:00 amRNSNet Asset Value(s)
8th Feb 202411:17 amRNSNet Asset Value(s)
23rd Jan 20249:41 amEQSEdison issues update on Baker Steel Resources Trust (BSRT): Strong revaluation boost from Futura
23rd Jan 20247:00 amRNSNet Asset Value(s)
19th Dec 20232:11 pmRNSHolding(s) in Company
19th Dec 202310:48 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSNet Asset Value(s)
1st Dec 20237:00 amRNSCompany Secretary Change
8th Nov 20237:00 amRNSNet Asset Value(s)
1st Nov 20237:00 amRNSChange of Custodian and Depositary
6th Oct 20237:00 amRNSNet Asset Value(s)
21st Sep 20235:34 pmRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSHalf-year Report
14th Sep 20234:22 pmRNSHolding(s) in Company
14th Sep 20233:38 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.